UNSPSC 85542108: Removal of nonautologous tissue substitute from lymphatic, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to removal of nonautologous tissue substitute from lymphatic, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 07PN0KZ

UNSPSC 85542108 Removal of nonautologous tissue substitute from lymphatic, open approach, a Commodity code, shows no recent state and local procurement activity aligned with its nominal medical procedure scope. The six opportunities posted between July and September 2026 that carry this code tag encompass independent medical evaluation services for disability pension determinations, surgical benefit carve-out programs, occupational medical surveillance, emergency and specialty healthcare for detained youth, pharmacy benefit management, and temporary health professional staffing — none involving lymphatic tissue removal or procedurally specific surgical intervention. The code appears to be a data-classification artifact; state and local health system and benefits procurement under this tag is driven by broader service contracting needs rather than the specific procedure the code nominally describes.

Recent activity reflects fragmented demand across multiple issuing bodies: the City of Phoenix Retirement Office (disability medical evaluation), City of Long Beach (surgical benefit network management), Washington State Department of Transportation (occupational medicine), Harris County Juvenile Probation Department (youth detention healthcare), Collier County Board of County Commissioners (pharmacy benefit administration), and Santa Clara County Health System (temporary staffing). Geographic spread spans Arizona, California, Washington, Florida, and Texas. The most substantive recent opportunity — Collier County's pharmacy benefit management RFP (RFP 25-8414, due April 9, 2026) — involves approximately $8.7 million in historical annual spending but targets formulary and claims administration rather than surgical procedures. Given the mismatch between the code's formal definition and the work actually tagged to it in active procurement, the code does not signal a reliable market segment for medical device or surgical service vendors.